Genetics-informed precision medicine
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
90
NCT07167758
A Study Evaluating TRIV-509 in Atopic Dermatitis
Phase: Phase 2
Role: Lead Sponsor
Start: Aug 26, 2025
Completion: Jun 30, 2027
Loading map...